Patients with advanced cancer were treated with immune checkpoint inhibitors and injected with COVID-19 vaccine to improve their prognosis without increasing pancreatic related adverse events

Min Lia Department of Oncology, The First Affiliated Hospital of Anhui Medical University, Hefei, ChinaView further author information

Lingling Liaoa Department of Oncology, The First Affiliated Hospital of Anhui Medical University, Hefei, ChinaView further author information

Wei Huanga Department of Oncology, The First Affiliated Hospital of Anhui Medical University, Hefei, ChinaView further author information

Hui Fengb Department of Gastroenterology, The First Affiliated Hospital of Anhui Medical University, Hefei, ChinaView further author information

Wanqing Wangc Department of Medical Imaging, The First Affiliated Hospital of Anhui Medical University, Hefei, ChinaView further author information

Nana Huanga Department of Oncology, The First Affiliated Hospital of Anhui Medical University, Hefei, ChinaView further author information

Zhiyan Zhaoa Department of Oncology, The First Affiliated Hospital of Anhui Medical University, Hefei, ChinaView further author information

Yu Shia Department of Oncology, The First Affiliated Hospital of Anhui Medical University, Hefei, ChinaView further author information

Jinglu Yed Department of Endocrinology, The Second Affiliated Hospital of Anhui Medical University, Hefei, ChinaCorrespondence[email protected]
View further author information

Kangsheng Gua Department of Oncology, The First Affiliated Hospital of Anhui Medical University, Hefei, ChinaCorrespondence[email protected]
View further author information

Your download is now in progress and you may close this window